Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Lipopolysaccharide antagonists.
Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin.
Veterans' Experiences With Outpatient Care: Comparing The Veterans Affairs System With?Community-Based Care.
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.
Precision Medicine for All?: What About Hypertrophic Cardiomyopathy?
See All 28 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision Medicine for All?: What About Hypertrophic Cardiomyopathy?
Maron BJ, Maron MS, Rowin EJ. Precision Medicine for All?: What About Hypertrophic Cardiomyopathy? JACC Adv. 2024 May; 3(5):100922.
View in:
PubMed
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD
Ethan Rowin MD, MBA